Cv Advisors LLC Moderna, Inc. Transaction History

Cv Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$118.38 - $210.04 $366,149 - $649,653	-3,093 Reduced 50.84%	2,991 $537,000
Q3 2022 Nov 07, 2022	SELL	$118.07 - $194.18 $200,246 - $329,329	-1,696 Reduced 21.8%	6,084 $719,000
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $172,766 - $260,470	-1,475 Reduced 15.94%	7,780 $1.11 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $124,563 - $231,524	-985 Reduced 9.62%	9,255 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $2.31 Million - $3.77 Million	10,240 New	10,240 $2.6 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cv Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cv Advisors LLC with notifications on news.